Risk factors for multidrug-resistant pathogens in bronchiectasis exacerbations

BMC Infectious Diseases

Table 3 Follow-up and outcome with regard to isolation multidrug-resistant pathogens or not in the exacerbation

Follow-up	No MDR^a	MDR^a	p ^b
Complications	18 (14.9)	4 (12.5)	0.733
Change in the initial treatment	27 (21.3)	10 (31.2)	0.232
Adequate initial treatment	108 (85)	24 (75)	0.176
Length of stay	8 (6–11)	8 (6–14)	0.925
Exacerbation year	69 (56.1)	25 (62.5)	0.514

Data are presented as n (%) or median (interquartile range)
^aMDR: Multidrug-resistant
^b p value: the χ² test was performed for categorical data and the Mann-Whitney U test was performed for continuous data

ISSN: 1471-2334